Job Opportunities API

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: The Director of Patient Marketing will lead the development and launch of patient-focused marketing strategy and messaging for our NSCLC portfolio. You will own the direct-to-patient strategy in a highly competitive oncology landscape and play a critical role in driving brand awareness, patient activation, and demand, while ensuring alignment with brand strategy, regulatory requirements, and corporate objectives. You will partner closely with HCP Marketing, Patient Advocacy, Market Access, Medical, Legal, Regulatory, Compliance, and Market Research / Analytics to deliver impactful, insights-driven campaigns that drive disease and brand awareness, patient activation, and brand demand. You are a leader that thrives in a fast-paced, launch-stage environment to help bring meaningful therapies to patients. Role and Responsibilities: Lead the development and execution of patient promotional strategies and tactics to support current and future oncology launches, with an initial focus on NSCLC Develop patient strategy, messaging, and value proposition grounded in market research, and translate insights into disease and treatment awareness initiatives that drive education, urgency, and patient activation Partner cross-functionally with HCP Marketing, Patient Advocacy, and Omnichannel Marketing to ensure cohesive brand strategy, alignment with patient community needs, and execution of an effective patient digital marketing approach Own the Patient Agency of Record (AOR) relationship, setting strategic direction and ensuring high-quality execution across creative, media, and digital initiatives Establish KPIs and performance metrics to measure campaign effectiveness, inform optimization, and guide ongoing patient channel strategy Manage patient promotional budgets to ensure efficient allocation of resources and maximize impact Travel as needed to support business priorities and engage with key stakeholders A